The Eyes Absent (EYA) proteins combine transactivation, tyrosine phosphatase, and threonine phosphatase activities in their function as part of a conserved regulatory cascade involved in embryonic organ development. EYA tyrosine phosphatase activity contributes to fly eye development, and vertebrate EYA is involved in promoting DNA damage repair subsequent to genotoxic stress. EYAs are known to be expressed at elevated levels in ovarian and breast cancers. Here, we show that the tyrosine phosphatase activity of the EYAs promotes tumor cell migration, invasion, and transformation. These cellular effects are accompanied by alterations of the actin cytoskeleton and increased levels of active Rac and Cdc42. The invasiveness conferred by EYA is reflected in vivo by inhibition of metastasis seen when EYA3 expression is silenced in the invasive breast cancer cell line MDA-MB-231. Together, our data directly associate the tyrosine phosphatase activity of the EYAs with the oncogenesis-associated cellular properties of motility and invasiveness.
Introduction
The retinal determination pathway is an evolutionarily conserved developmental cascade known to be involved in cell-fate determination in multiple contexts (eye, kidney, muscle, ear) , and in species ranging from flies to human beings (reviewed in Hanson, 2001 ). The components of this genetic network in vertebrates (and Drosophila) include the Pax (eyeless (ey) and twin of eyeless (toy)), Eyes Absent (Eya (eya)), Six (sine oculis (so) and optix), and Dachshund (dac) genes. Evidence is emerging that this network is aberrantly expressed in adult cancers, in a seemingly coordinated manner in which Eya and Six genes are up-regulated and Dach genes are down-regulated. There are reports of upregulation of Six1 in breast cancers (Ford et al., 1998 (Ford et al., , 2000 Coletta et al., 2004; Reichenberger et al., 2005) , Wilms' tumor (Li et al., 2002) , and in rhabdomyosarcomas (Yu et al., 2004 (Yu et al., , 2006 , Six3 in human extraskeletal myxoid sarcomas (Laflamme et al., 2003; Hisaoka et al., 2004) , and Six5 in borderline ovarian tumors (Winchester et al., 2000) . Eya2 levels are reportedly higher in breast and ovarian cancers , and in desmoid tumors (Bacac et al., 2006) , whereas Eya1 is over-expressed in Wilms' tumor (Li et al., 2002) . On the other hand, Dach1 expression is lost in breast cancers with poor prognosis (Wu et al., 2006 (Wu et al., , 2007 (Wu et al., , 2008 . Six1 and Eya4 are also up-regulated in malignant peripheral nerve sheath tumors, whereas Dach1 is down-regulated (Miller et al., 2010) . This coordinated dysregulation of the retinal determination genes is consistent with other examples of genetic programs involved in normal development being co-opted in the process of carcinogenesis.
Proteins encoded by the Pax, Six, and Dach genes are transcription factors, whereas the Eyes Absent (EYA) genes encode dual-function transactivator-phosphatase proteins (Ikeda et al., 2002; Li et al., 2003; Rayapureddi et al., 2003; Tootle et al., 2003; Jemc and Rebay, 2007; Okabe et al., 2009) . The biochemical activities of the EYA proteins reside in separable domains: the N-terminal transactivation and threonine phosphatase domain and the C-terminal tyrosine phosphatase domain (ED). In concert with the homeodomain DNA-binding SIX proteins, EYA is known to regulate the expression of several genes including c-Myc, Gdnf, muscle determination genes such as Myod, Mrf4, and Myogenin. Transcriptional targets of the Drosophila EYA-SO complex include lozenge, sine oculis itself, eyeless, hedgehog, and atonal (Pauli et al., 2005; Zhang et al., 2006) . Experiments in Drosophila have shown that the phosphatase activity of eya contributes to fly eye development (Rayapureddi et al., 2003; Tootle et al., 2003) . Although recent reports link the nuclear tyrosine phosphatase activity of EYA with DNA damage repair (Cook et al., 2009; Krishnan et al., 2009) , the EYA tyrosine phosphatase activity has also been linked to a cytoplasmic-cellular function (Xiong et al., 2009) . We are interested in understanding how the biochemical activities of the EYA proteins might contribute to cellular properties characteristic of malignant tumor cells.
In this report, we show that over-expression of Eya1, Eya2, or Eya3 results in increased proliferation, migration, invasion, and transformation of breast cancer cells. Interestingly, only the cellular functions of migration, invasion, and transformation are dependent on the phosphatase activity. The function of Eya3 in promoting invasion is also supported by in vivo metastasis studies showing that silencing of EYA3 expression in MDA-MB-231 cells leads to reduced metastasis. Taken together, our data suggest that the over-expression of EYA proteins in mammary epithelial cells can promote tumorigenesis, and that their phosphatase activity can specifically contribute to increased invasiveness.
Results

EYA-promoted cell proliferation does not require the phosphatase activity
To examine the effect of EYA over-expression in cells, we established stable MCF7 cell lines over-expressing Eya1, Eya2, or Eya3 as GFP fusions, as well as a cell line expressing the vector-control GFP alone. We chose Eya3 and Eya2 for more extensive analysis in this study, as Eya3 is mechanistically the best characterized of the mammalian EYA proteins (Rayapureddi et al., 2003 (Rayapureddi et al., , 2005 Rayapureddi and Hegde, 2006) and Eya2 has been reported to be elevated in ovarian and breast cancers . To examine the effect of Eya3 dose on cellular functions, we also established two independent clones expressing different levels of Eya3-GFP. Over-expression resulted in significantly increased cell proliferation as measured in a WST assay (Figure 1a) . The dependence of the pro-proliferative effect on the tyrosine phosphatase activity of the Eya proteins was tested by over-expressing phosphatase-deficient forms of Eya1, Eya2, or Eya3 (Figures 1a and b) and measuring proliferation. In each case, the nucleophilic Aspartate was conservatively replaced with an Asparagine; such a substitution has been shown to significantly reduce the phosphatase activity of the Eyas (Rayapureddi et al., 2003) . Proliferation of MCF7 cells stably over-expressing the mutant forms (Eya3(D246N), Eya2(D209N), or Eya1(D299N)) exhibited statistically insignificant differences in the levels of proliferation relative to overexpression of the wild-type proteins (Figures 1a and b) , suggesting that the tyrosine phosphatase activity does not contribute to cell proliferation.
EYA phosphatase activity promotes cell migration, invasion, and transformation Cell migration was measured using transwell assays and the MCF7 cell lines described above. MCF7 cells overexpressing Eya3 (Figure 2a) , Eya1, or Eya2 (Figure 2b ) each exhibited significantly higher cell migration relative to MCF7 cells expressing the vector control. A similar effect was seen on over-expressing Eya3 in MDA-MB-231 cells (Figure 2a ). This effect on cell motility was consistently attenuated when the tyrosine phosphatasedead forms of the Eyas (Eya3(D246N), Eya2(D209N), and Eya1(D299N)) were over-expressed (Figures 2a and b) . Similar results were obtained with another tyrosinephosphatase-dead mutant Eya3(D248N) in which the Asp248, which acts as a general acid in the catalytic reaction (Rayapureddi et al., 2003) , is replaced by an Asn, and using differently tagged Eya3 in COS7 cells (Supplementary Figure 2) . These observations suggest that the tyrosine phosphatase activity of the Eyas positively impacts cell motility. Cell motility was also increased on over-expression of just the C-terminal tyrosine phosphatase domain of Eya3 (Eya3(ED)), but not the inactive mutant Eya3(ED)(D248N) (Figure 2a ). However, in MCF7 cells expressing Eya3 targeted to the nucleus by the addition of the nuclear localization Eyes Absent promotes cell migration and invasion RN Pandey et al signal from SV40 large T-antigen (PKKKRKV) at the C-terminus of the protein, no increase in motility above that of the parental MCF7 cells was measured ( Figure 2a ). Together, these data support a function in cell migration for the tyrosine phosphatase activity residing in the C-terminal ED domain of Eya. These results were mirrored when the invasive potential of MCF7 and MDA-MB-231 cells expressing the forms of Eya3 or Eya2 described above was measured using transwells coated with matrigel ( Figure 2c ). In each case, there was a clear increase in invasiveness on Eya3 over-expression that was significantly lower when Eya3(D246N) was over-expressed, supporting a positive function for the Eya phosphatase activity in promoting cell invasion. When EYA3 mRNA was silenced using siRNA in MDA-MB-231 cells, both migration and invasion were reduced relative to the same cells expressing a scramble control (Figure 2d ). Cell motility was rescued on re-expression of Eya3, but not Eya3(D246N), in the siEYA3-containing cells.
The ability of the Eyas to transform cells was measured using focus formation assays (Figures 3a  and b) . Eya1, 2, or 3 over-expression resulted in a significant increase in transformation as measured by the number of foci. In all cases, the effect was dependent on the tyrosine phosphatase activity as judged by the fewer foci seen in cells expressing the phosphatase-dead mutant forms of the proteins. As a positive control in these experiments, we used MCF7 cells stably expressing constitutively active Ras(Q61L). Notably, Eya overexpression not only increased the number of foci, but also accelerated the rate of focus formation relative to MCF7-Ras(Q61L) (Figure 3c ), supporting a function for the Eyas as potent mediators of cellular transformation.
Eya3 causes changes in the actin cytoskeleton
In further investigations of the cellular function(s) of the EYA phosphatase activity, we focused on Eya3 and Eya2. We first examined how the EYAs affect the actin cytoskeleton and found that MCF7 cells over-expressing either Eya3, Eya2, Eya2(D209N), or Eya3(D246N) were morphologically distinct from the parental MCF7 cells or those expressing the vector control (Figure 4a ). The Eya3 and Eya2 over-expressing cells were more rounded and phalloidin staining indicated that they had fewer stress fibers. Cortical actin and many filopodia and lamellipodia were present. In contrast, the Eya3(D246N) or Eya2(D209N) over-expressing cells were relatively flat and spread, and had more prominent stress fibers.
As regulation of the actin cytoskeleton is closely linked with the activation states of the Rho family of GTPases, we compared the levels of active Rho, Rac, and Cdc42 in MCF7 cells over-expressing Eya2 or Eya2(D209N) relative to cells expressing the vector control. GST-Rhotekin (for RhoA) or GST-PAK (for Rac and Cdc42) was used for the selective pulldown of the GTP-bound forms. The data indicate increase in Rac and Cdc42 activation in cells expressing Eya2 or Eya3 (Figure 4b ). GTP-Rac promotes the formation of lamellipodia at the leading edge of a moving cell, whereas GTP-Cdc42 is associated with the formation of filopodia, cell polarization, and directional cell movement (Ridley et al., 2003) . In contrast, the level of GTP-RhoA was increased in MCF7-Eya2(D209N) and Eya3(D246N) cells, consistent with the observed increase in stress fibers (Figure 4a ). These observations suggest that the EYA tyrosine phosphatase activity can produce opposing effects on Rho and Rac/Cdc42 activities, which could in turn influence cell motility and the actin cytoskeleton.
Eya3 contributes to metastasis of breast cancer cell lines in vivo
We next used an in vivo assay to establish whether EYA3 has a function in the metastatic activity of MDA-MB-231 cells. MDA-MB-231 expresses EYA3 and produces lung metastases (Richert et al., 2005) . Thus, it was a good candidate for RNAi knockdown-mediated assessment of EYA3 function in metastasis. MDA-MB-231 cells stably expressing either a scramble-control RNA, EYA3 siRNA, EYA3 siRNA along with mouse Eya3, or Eya3 siRNA along with mouse Eya3(D246N) were injected into the tail vein of immunodeficient SCID mice at 5-6 weeks of age and lung metastases visualized 7 weeks later. Metastases, appearing as white regions of tissue against a black background of the ink-filled lung were counted and a statistical analysis performed. This Figure 4 Eyes Absent affects the actin cytoskeleton and levels of active Rho-family GTPases. (a) Eya3 or Eya2 over-expression induces the formation of filopodia and lamellipodia, whereas the mutants Eya3(D246N) and Eya2(D209N) lead to cell flattening and stress fiber formation. MCF7 cells stably expressing GFP, Eya3-GFP, Eya2-GFP, Eya2(D209N)-GFP, or Eya3(D246N)-GFP were plated on laminin-coated slides. Cells were fixed, stained for F-actin (red) and DAPI (blue), and photographed after 1 h. The lower panel shows images taken on a Leica TCS-SP5 confocal microscope. (b) MCF7 cells expressing either the vector control, Eya3-GFP, Eya3(D246N)-GFP, Eya2-GFP, or Eya2(D209N)-GFP were serum starved and then stimulated with 10% serum for 15 min. Whole cell lysates were subject to GST-RBD or GST-PAK pull-down and immunoblotted for RhoA, Rac1, or Cdc42. The GTP-bound forms of RhoA, Rac1, and Cdc42 were normalized to loading control and the average relative activation is shown in the bar graph (average of three experiments).
showed that parental MDA-MB-231 cells produced significantly more metastases than those expressing EYA3 siRNA ( Figure 5 ). MDA-MB-231 EYA3 siRNA cells also produced smaller metastases than control MDA-MB-231 cells. In the rescue experiments, reexpression of wild-type Eya3 lead to near-control level metastasis, whereas re-expression of the tyrosine-phosphatase-dead mutant Eya3(D246N) did not. These results indicate that, consistent with the in vitro observations presented earlier, E3 is a determinant of metastatic behavior in these tumor cells, and that this function needs the tyrosine phosphatase activity.
Discussion
Phosphatases have important functions in regulating cell migration by altering the phosphorylation state of proteins involved in focal adhesion and extra-cellular matrix interactions. This in turn can alter the actin cytoskeleton through the Rho-family GTPases (reviewed in Larsen et al., 2003; Ostman et al., 2006) . Protein tyrosine phosphatases that both promote (PRL PTPs (Fiordalisi et al., 2006) ; PTP1B ), and inhibit (HD-PTP (Castiglioni et al., 2007; Mariotti et al., 2009) ; DEP-1 (Jandt et al., 2003) ) cell motility and invasiveness have been reported. Our results provide evidence that the EYA family of tyrosine phosphatases promotes cell migration, invasion, and transformation, and that these functions require the phosphatase activity. This observation has important implications for the function of the EYAs in cell-fate determination during embryonic development, as well as possibly in cancer metastasis.
A link between the EYA phosphatase activity and cell motility/invasiveness complements a recent report suggesting that phosphorylation of Drosophila Eya by Abl shuttles it to the cytoplasm in which it carries out an, as yet undefined, essential cellular function (Xiong et al., 2009) . The effects of Eya on cell motility and the actin cytoskeleton reported here are consistent with a cytoplasmic function of the Eya phosphatase, distinct from the recently reported nuclear dephosphorylation of H2AX (Cook et al., 2009; Krishnan et al., 2009) . The cytoplasmic substrate(s) of Eya remain to be elucidated, but a direct link with a cellular function such as cell motility could provide a critical readout for validating such a target once it is identified.
Over-expression of the Eyas also promotes cell proliferation. However, our data suggest that cell proliferation is not dependent on the phosphatase activity, but rather that the transactivation function of Eya may be the more important contributor. In keeping with our observations, Kriebel et al. (2007) recently reported that over-expression of Xeya3 in Xenopus results in an expansion of the neural plate, and dramatically enlarged brain structures and eyes at the tailbud stage. Further, they have shown that phosphatase-deficient forms of Xeya3 enhance the observed neural hyperplasia above that seen with wild-type Xeya3. The eya over-expression also leads to increased tissue overgrowth in Drosophila (Bonini et al., 1997) . Commensurate with a function for Eya in cell proliferation are earlier reports that cell cycle regulatory genes cyclin D1 and cyclin A1 (Coletta et al., 2004; Yu et al., 2006) , and the proto-oncogene c-Myc (Li et al., 2003) are transcriptional targets of the mammalian Eya-Six protein complex. While proliferation is not tyrosine phosphatase-activity dependent, the reduced contact inhibition of cell growth seen in the transformation assays is dependent on the phosphatase activity. Although the mechanisms underlying contact inhibition are incompletely understood, there is precedent for the mediation of cell transformation by tyrosine phosphatases (Agazie et al., 2003) .
The retinal determination genes EYA, SIX, and DACH seem to be coordinately de-regulated in a variety of malignant conditions including ovarian and breast tumors, and malignant peripheral nerve sheath tumors. The recurring trend is that EYA and SIX expression is increased and DACH expression reduced. In this context, it is interesting to note that the pro-proliferation and pro-migratory effects of EYA over-expression reported here are mirrored when Dachshund levels are lowered in breast cancer cells (Wu et al., 2006 (Wu et al., , 2008 . Mice were killed 7 weeks after injection. Lungs were removed, bleached, and examined for surface metastasis after India ink injection. The number of metastatic foci in the largest left lobe examined were counted and shown as a box plot. The horizontal black line is the median value, the box represents the inter-quartile range (25-75% of the distribution), and the line bars the minimum and maximum values.
Furthermore, increased proliferation has been noted on SIX1 over-expression in breast cancer (Coletta et al., 2004; Christensen et al., 2007) . Taken together, these observations suggest that mis-deployment of this cellfate determination cascade could contribute to increased tumor malignancy and poorer clinical outcomes.
The ability of EYA2 to promote tumor growth in a xenograft model was described earlier . Interestingly, despite the in vivo evidence linking EYA2 over-expressing cells with high proliferative rates, there seemed to be no effect of EYA2 over-expression on the cell cycle or on cell proliferation in vitro using several ovarian cancer cell lines and MDA-MB-468 . In contrast, our data show a clear and positive correlation between Eya over-expression and cell proliferation in MCF7 cells. Furthermore, the positive correlation between EYA levels and cell motility is consistently seen both in vitro (cell migration) and in vivo (tumor metastasis). Together, these data link each of the biochemical activities of the EYA proteins, transactivation and tyrosine phosphatase, with cancer phenotypes.
Finally, the association of the tyrosine phosphatase function of EYA with a cancer-associated cellular phenotype raises the distinct possibility that inhibition of the EYA phosphatases could be an attractive new mode of targeted anti-cancer therapy. As targets for inhibitor design, the EYAs possess a distinct advantage; they are mechanistically and structurally distinct from the large family of classical thiol-based PTPs thus increasing the feasibility of selective inhibition.
Materials and methods
Proliferation assays MCF-7 stable lines were analyzed for their proliferation rates using the GFP-MCF-7 line as a control and a WST-1 assay (Takamatsu, 1998) .
Cell migration and invasion assays
Cell migration assays were performed using transwell inserts. Cell invasion was also measured using a transwell assay as above except that the filters were coated with basement membrane Matrigel (1:20 dilution).
Focus formation assay
Focus formation was measured at days 6 and 13 in which a focus was defined as group of cells growing on top of each other in which a noticeable change in contrast was observed under Hoffman Optics. All experiments were conducted in triplicate.
Immunostaining
Cells were plated on a cover-slip coated with 5mg/ml laminin, and fixed with 4% paraformaldehyde. Actin fibers were stained using Alexa-594-labeled phalloidin (Invitrogen, Carlsbad, CA, USA).
Rho/Rac/Cdc42 GTPase-activity assays Levels of GTP-bound RhoA, Rac1, and Cdc42 were measured in MCF7 cells stably expressing either GFP, Eya3-GFP, Eya3(D246N)-GFP, Eya2-GFP, or Eya2(D209N)-GFP after 15 min serum stimulation. Levels of total and active proteins were determined by western blot analyses using anti-Rho antibody (Cell Biolabs, San Diego, CA, USA), anti-Rac1 (Cell Biolabs), and anti-Cdc42 (Santa Cruz, Santa Cruz, CA, USA) antibodies.
Analysis of lung metastasis in SCID mice
To produce experimental lung metastasis, MDA-MB-231 cells stably expressing either scramble-control RNA, EYA3 siRNA, EYA3 siRNA with mouse Eya3, or EYA3 siRNA with mouse Eya3(D246N) were transplanted into female SCID mice (5-6 weeks old) through lateral tail vein injection. All mice were killed 7 weeks after injection, stained with India ink and metastatic foci were counted. Data are presented as a box plot using SPSS software.
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